CN103278468A - 一种肌酐检测试剂 - Google Patents
一种肌酐检测试剂 Download PDFInfo
- Publication number
- CN103278468A CN103278468A CN2013102005202A CN201310200520A CN103278468A CN 103278468 A CN103278468 A CN 103278468A CN 2013102005202 A CN2013102005202 A CN 2013102005202A CN 201310200520 A CN201310200520 A CN 201310200520A CN 103278468 A CN103278468 A CN 103278468A
- Authority
- CN
- China
- Prior art keywords
- damping fluid
- reagent
- creatinine
- sulfonic acid
- detects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 58
- 229940109239 creatinine Drugs 0.000 title claims abstract description 39
- 238000001514 detection method Methods 0.000 title abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 11
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- 108010060059 Sarcosine Oxidase Proteins 0.000 claims abstract description 8
- 102000008118 Sarcosine oxidase Human genes 0.000 claims abstract description 8
- 108010066906 Creatininase Proteins 0.000 claims abstract description 7
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 6
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 6
- 238000004108 freeze drying Methods 0.000 claims abstract description 6
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 239000004094 surface-active agent Substances 0.000 claims abstract description 5
- 239000012530 fluid Substances 0.000 claims description 48
- 238000013016 damping Methods 0.000 claims description 44
- 238000010790 dilution Methods 0.000 claims description 19
- 239000012895 dilution Substances 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- 230000002421 anti-septic effect Effects 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical class COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 6
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 230000002452 interceptive effect Effects 0.000 claims description 5
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical class [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 5
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 claims description 4
- PAFZNILMFXTMIY-UHFFFAOYSA-N Cyclohexylamine Natural products NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 claims description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 4
- 229920000136 polysorbate Polymers 0.000 claims description 4
- 229920000053 polysorbate 80 Polymers 0.000 claims description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 4
- -1 trihydroxy methyl Chemical group 0.000 claims description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 3
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 3
- 108010015428 Bilirubin oxidase Proteins 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 239000000276 potassium ferrocyanide Substances 0.000 claims description 3
- 235000010241 potassium sorbate Nutrition 0.000 claims description 3
- 239000004302 potassium sorbate Substances 0.000 claims description 3
- 229940069338 potassium sorbate Drugs 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 235000010288 sodium nitrite Nutrition 0.000 claims description 3
- XOGGUFAVLNCTRS-UHFFFAOYSA-N tetrapotassium;iron(2+);hexacyanide Chemical compound [K+].[K+].[K+].[K+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] XOGGUFAVLNCTRS-UHFFFAOYSA-N 0.000 claims description 3
- CKQPAVCUJDZLLE-UHFFFAOYSA-N 1,3-dihydroxy-2-(methylamino)butane-2-sulfonic acid Chemical compound CNC(CO)(C(C)O)S(O)(=O)=O CKQPAVCUJDZLLE-UHFFFAOYSA-N 0.000 claims description 2
- XMGKYXFDYYTZFD-UHFFFAOYSA-N 4-amino-1-hydroxy-2-methylbutane-2-sulfonic acid Chemical compound OCC(C)(S(O)(=O)=O)CCN XMGKYXFDYYTZFD-UHFFFAOYSA-N 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 2
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- XPJVKCRENWUEJH-UHFFFAOYSA-N Isobutylparaben Chemical compound CC(C)COC(=O)C1=CC=C(O)C=C1 XPJVKCRENWUEJH-UHFFFAOYSA-N 0.000 claims description 2
- CMHMMKSPYOOVGI-UHFFFAOYSA-N Isopropylparaben Chemical compound CC(C)OC(=O)C1=CC=C(O)C=C1 CMHMMKSPYOOVGI-UHFFFAOYSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- QDPMLKBAQOZXEF-UHFFFAOYSA-N ethanesulfonic acid;sodium Chemical compound [Na].CCS(O)(=O)=O QDPMLKBAQOZXEF-UHFFFAOYSA-N 0.000 claims description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 2
- 229960003415 propylparaben Drugs 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 2
- 229930003268 Vitamin C Natural products 0.000 abstract description 2
- 235000019154 vitamin C Nutrition 0.000 abstract description 2
- 239000011718 vitamin C Substances 0.000 abstract description 2
- 239000000872 buffer Substances 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 2
- 239000003755 preservative agent Substances 0.000 abstract 2
- 230000002335 preservative effect Effects 0.000 abstract 2
- 108010077078 Creatinase Proteins 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- RMBFPIDRGHVESJ-UHFFFAOYSA-N propyl N-ethyl-N-(3-methylphenyl)sulfamate Chemical compound C(C)N(C1=CC(=CC=C1)C)S(=O)(=O)OCCC RMBFPIDRGHVESJ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003223 protective agent Substances 0.000 abstract 1
- 238000012123 point-of-care testing Methods 0.000 description 22
- 238000005516 engineering process Methods 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 7
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 229960003624 creatine Drugs 0.000 description 3
- 239000006046 creatine Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000024924 glomerular filtration Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200520.2A CN103278468B (zh) | 2013-05-24 | 2013-05-24 | 一种肌酐检测试剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310200520.2A CN103278468B (zh) | 2013-05-24 | 2013-05-24 | 一种肌酐检测试剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103278468A true CN103278468A (zh) | 2013-09-04 |
CN103278468B CN103278468B (zh) | 2015-09-02 |
Family
ID=49061051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310200520.2A Active CN103278468B (zh) | 2013-05-24 | 2013-05-24 | 一种肌酐检测试剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103278468B (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104459164A (zh) * | 2014-11-28 | 2015-03-25 | 山东博科生物产业有限公司 | 一种血清肌酐检测试剂 |
CN105203472A (zh) * | 2015-06-30 | 2015-12-30 | 北京万泰德瑞诊断技术有限公司 | 一种稳定的游离脂肪酸测定试剂盒 |
CN106124779A (zh) * | 2016-06-15 | 2016-11-16 | 四川迈克生物科技股份有限公司 | 一种用于测定肌酐的试剂盒和方法 |
CN106353511A (zh) * | 2016-08-19 | 2017-01-25 | 基蛋生物科技股份有限公司 | 一种尿微量白蛋白/尿肌酐一体化检测二联条及其制备方法 |
CN106383237A (zh) * | 2016-08-19 | 2017-02-08 | 基蛋生物科技股份有限公司 | 一种干片式血清肌酐检测试剂条及其制备方法 |
CN106556595A (zh) * | 2015-09-30 | 2017-04-05 | 山东博科生物产业有限公司 | 一种抗干扰能力强的肌酐苦味酸法检测试剂盒 |
CN107505470A (zh) * | 2017-08-10 | 2017-12-22 | 威特曼生物科技(南京)有限公司 | 稳定的肌酐检测试剂盒及其使用方法 |
CN108627654A (zh) * | 2018-06-25 | 2018-10-09 | 武汉瀚海新酶生物科技有限公司 | 用于消除羟苯磺酸钙药物对肌酐酶法检测干扰的组合物 |
CN109287661A (zh) * | 2018-11-13 | 2019-02-01 | 武汉瀚海新酶生物科技有限公司 | 一种用于酶法肌酐试剂防腐的防腐剂组合物 |
CN109406798A (zh) * | 2018-10-29 | 2019-03-01 | 美康生物科技股份有限公司 | 肌酐酶法检测试剂盒 |
CN109613274A (zh) * | 2018-12-28 | 2019-04-12 | 上海高踪医疗器械科技有限公司 | 一种测定肌酐的试剂盒及方法 |
CN111944872A (zh) * | 2020-08-31 | 2020-11-17 | 柏定生物工程(北京)有限公司 | 测定肌酐含量的试剂组合、试剂或试剂盒 |
CN112522364A (zh) * | 2020-08-15 | 2021-03-19 | 中山标佳生物科技有限公司 | 一种快速简易消除血清中羟苯磺酸钙、酚磺乙胺药物干扰的尿酸试剂盒 |
CN113075142A (zh) * | 2021-03-31 | 2021-07-06 | 长沙中生众捷生物技术有限公司 | 一种肌酐测试试条及其应用 |
CN113514451A (zh) * | 2021-04-19 | 2021-10-19 | 深圳市锦瑞生物科技有限公司 | 一种血肌酐检测试剂球及血肌酐检测芯片 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61155758A (ja) * | 1984-12-27 | 1986-07-15 | Kobayashi Seiyaku Kk | クレアチニン及びクレアチンの同時定量方法並びにそのキツト |
CN1766637A (zh) * | 2004-10-28 | 2006-05-03 | 王尔中 | 肌酐含量测定方法及肌酐诊断试剂盒 |
CN1912594A (zh) * | 2006-08-10 | 2007-02-14 | 福建省洪诚生物药业有限公司 | 血清中肌酐的化学发光测定方法 |
CN101097198A (zh) * | 2006-06-26 | 2008-01-02 | 苏州艾杰生物科技有限公司 | 肌酐诊断试剂盒及肌酐浓度的测定方法 |
CN101865911A (zh) * | 2010-03-16 | 2010-10-20 | 苏州市玮琪生物科技有限公司 | 一种尿肌酐定量检测卡 |
CN102023158A (zh) * | 2010-10-19 | 2011-04-20 | 李立和 | 血清中肌酐的两步酶测定方法 |
CN102253041A (zh) * | 2011-06-20 | 2011-11-23 | 董理 | 一种检测肌酐的试剂盒 |
CN102375066A (zh) * | 2011-09-20 | 2012-03-14 | 天津希恩思生化科技有限公司 | 一种肌酸酐含量检测试剂和试剂盒,及试剂盒的制作和使用方法 |
CN102721684A (zh) * | 2012-05-24 | 2012-10-10 | 宁波美康生物科技股份有限公司 | 血清中肌酐的二步酶法测定方法及测定试剂 |
CN102757893A (zh) * | 2011-04-28 | 2012-10-31 | 爱科来株式会社 | 肌酸酐测定用干式试验片及肌酸酐测定法 |
-
2013
- 2013-05-24 CN CN201310200520.2A patent/CN103278468B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61155758A (ja) * | 1984-12-27 | 1986-07-15 | Kobayashi Seiyaku Kk | クレアチニン及びクレアチンの同時定量方法並びにそのキツト |
CN1766637A (zh) * | 2004-10-28 | 2006-05-03 | 王尔中 | 肌酐含量测定方法及肌酐诊断试剂盒 |
CN101097198A (zh) * | 2006-06-26 | 2008-01-02 | 苏州艾杰生物科技有限公司 | 肌酐诊断试剂盒及肌酐浓度的测定方法 |
CN1912594A (zh) * | 2006-08-10 | 2007-02-14 | 福建省洪诚生物药业有限公司 | 血清中肌酐的化学发光测定方法 |
CN101865911A (zh) * | 2010-03-16 | 2010-10-20 | 苏州市玮琪生物科技有限公司 | 一种尿肌酐定量检测卡 |
CN102023158A (zh) * | 2010-10-19 | 2011-04-20 | 李立和 | 血清中肌酐的两步酶测定方法 |
CN102757893A (zh) * | 2011-04-28 | 2012-10-31 | 爱科来株式会社 | 肌酸酐测定用干式试验片及肌酸酐测定法 |
CN102253041A (zh) * | 2011-06-20 | 2011-11-23 | 董理 | 一种检测肌酐的试剂盒 |
CN102375066A (zh) * | 2011-09-20 | 2012-03-14 | 天津希恩思生化科技有限公司 | 一种肌酸酐含量检测试剂和试剂盒,及试剂盒的制作和使用方法 |
CN102721684A (zh) * | 2012-05-24 | 2012-10-10 | 宁波美康生物科技股份有限公司 | 血清中肌酐的二步酶法测定方法及测定试剂 |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104459164A (zh) * | 2014-11-28 | 2015-03-25 | 山东博科生物产业有限公司 | 一种血清肌酐检测试剂 |
CN105203472A (zh) * | 2015-06-30 | 2015-12-30 | 北京万泰德瑞诊断技术有限公司 | 一种稳定的游离脂肪酸测定试剂盒 |
CN105203472B (zh) * | 2015-06-30 | 2019-03-08 | 北京万泰德瑞诊断技术有限公司 | 一种稳定的游离脂肪酸测定试剂盒 |
CN106556595A (zh) * | 2015-09-30 | 2017-04-05 | 山东博科生物产业有限公司 | 一种抗干扰能力强的肌酐苦味酸法检测试剂盒 |
CN106556595B (zh) * | 2015-09-30 | 2019-04-30 | 山东博科生物产业有限公司 | 一种抗干扰能力强的肌酐苦味酸法检测试剂盒 |
CN106124779B (zh) * | 2016-06-15 | 2019-10-18 | 中国医学科学院北京协和医院 | 一种用于测定肌酐的试剂盒和方法 |
CN106124779A (zh) * | 2016-06-15 | 2016-11-16 | 四川迈克生物科技股份有限公司 | 一种用于测定肌酐的试剂盒和方法 |
CN106353511A (zh) * | 2016-08-19 | 2017-01-25 | 基蛋生物科技股份有限公司 | 一种尿微量白蛋白/尿肌酐一体化检测二联条及其制备方法 |
CN106383237A (zh) * | 2016-08-19 | 2017-02-08 | 基蛋生物科技股份有限公司 | 一种干片式血清肌酐检测试剂条及其制备方法 |
CN107505470A (zh) * | 2017-08-10 | 2017-12-22 | 威特曼生物科技(南京)有限公司 | 稳定的肌酐检测试剂盒及其使用方法 |
CN108627654A (zh) * | 2018-06-25 | 2018-10-09 | 武汉瀚海新酶生物科技有限公司 | 用于消除羟苯磺酸钙药物对肌酐酶法检测干扰的组合物 |
CN108627654B (zh) * | 2018-06-25 | 2021-03-16 | 武汉瀚海新酶生物科技有限公司 | 用于消除羟苯磺酸钙药物对肌酐酶法检测干扰的组合物 |
CN109406798A (zh) * | 2018-10-29 | 2019-03-01 | 美康生物科技股份有限公司 | 肌酐酶法检测试剂盒 |
CN109287661A (zh) * | 2018-11-13 | 2019-02-01 | 武汉瀚海新酶生物科技有限公司 | 一种用于酶法肌酐试剂防腐的防腐剂组合物 |
CN109613274A (zh) * | 2018-12-28 | 2019-04-12 | 上海高踪医疗器械科技有限公司 | 一种测定肌酐的试剂盒及方法 |
CN112522364A (zh) * | 2020-08-15 | 2021-03-19 | 中山标佳生物科技有限公司 | 一种快速简易消除血清中羟苯磺酸钙、酚磺乙胺药物干扰的尿酸试剂盒 |
CN112522364B (zh) * | 2020-08-15 | 2023-09-08 | 中山标佳生物科技有限公司 | 一种快速简易消除血清中羟苯磺酸钙、酚磺乙胺药物干扰的尿酸试剂盒 |
CN111944872A (zh) * | 2020-08-31 | 2020-11-17 | 柏定生物工程(北京)有限公司 | 测定肌酐含量的试剂组合、试剂或试剂盒 |
CN113075142A (zh) * | 2021-03-31 | 2021-07-06 | 长沙中生众捷生物技术有限公司 | 一种肌酐测试试条及其应用 |
CN113075142B (zh) * | 2021-03-31 | 2023-10-03 | 复星诊断科技(长沙)有限公司 | 一种肌酐测试试条及其应用 |
CN113514451A (zh) * | 2021-04-19 | 2021-10-19 | 深圳市锦瑞生物科技有限公司 | 一种血肌酐检测试剂球及血肌酐检测芯片 |
CN113514451B (zh) * | 2021-04-19 | 2023-12-22 | 深圳市锦瑞生物科技股份有限公司 | 一种血肌酐检测试剂球及血肌酐检测芯片 |
Also Published As
Publication number | Publication date |
---|---|
CN103278468B (zh) | 2015-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103278468B (zh) | 一种肌酐检测试剂 | |
CN103278648B (zh) | 一种白蛋白检测试剂 | |
CN103276052B (zh) | 一种尿素氮检测试剂 | |
CN103266166B (zh) | 一种葡萄糖检测试剂 | |
US11808777B2 (en) | Method of analyzing diluted biological sample component | |
CN103320498B (zh) | 一种天冬氨酸氨基转移酶检测试剂 | |
CN103278469B (zh) | 一种总蛋白检测试剂 | |
CN104459164A (zh) | 一种血清肌酐检测试剂 | |
CN103320497B (zh) | 一种丙氨酸氨基转移酶检测试剂 | |
CN103278652B (zh) | 一种总胆红素检测试剂 | |
CN104198473A (zh) | 一种稳定的尿酸检测试剂盒 | |
CN104198408A (zh) | 酶法测定血清中肌酐含量的检测试剂盒 | |
CN103276051B (zh) | 一种碱性磷酸酶检测试剂 | |
CN103266165B (zh) | 一种淀粉酶检测试剂 | |
CN102041296A (zh) | 一种血清低密度脂蛋白胆固醇(ldl-c)匀相法体外诊断试剂 | |
CN103266164B (zh) | 一种亮氨酸氨基肽酶检测试剂 | |
Marakala et al. | Serum creatinine assay: enzymatic vs kinetic Jaffe’s method | |
CN104673880A (zh) | 一种小而密低密度脂蛋白胆固醇检测试方法 | |
CN103333945B (zh) | 一种直接胆红素检测试剂 | |
Matteucci et al. | Point-of-care testing in diabetes care | |
CN104678107A (zh) | 一种游离脂肪酸的定量测定方法、试剂及试剂盒 | |
CN103290097A (zh) | 一种γ-谷氨酰基转移酶检测试剂 | |
Fraser et al. | Better laboratory evaluations of instruments and kits are required. | |
CN108070634B (zh) | 糖尿病三项联合检测试剂盘 | |
CN101762543A (zh) | 乙醇诊断/测定试剂(盒)及乙醇浓度测定方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zou Bingde Inventor after: Zou Jihua Inventor after: Wo Yanbo Inventor after: Zhang Guichun Inventor after: Gu Yongmei Inventor before: Zou Bingde Inventor before: Zou Jihua Inventor before: Wo Yanbo Inventor before: Zhang Guichun Inventor before: Gu Yongmei Inventor before: Zhou Haibin |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZOU BINGDE ZOU JIHUA WO YANBO ZHANG GUICHUN GU YONGMEI ZHOU HAIBIN TO: ZOU BINGDE ZOU JIHUA WO YANBO ZHANG GUICHUN GU YONGMEI |
|
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Zou Bingde Inventor after: Zou Jihua Inventor after: Wo Yanbo Inventor after: Zhang Guichun Inventor before: Zou Bingde Inventor before: Zou Jihua Inventor before: Wo Yanbo Inventor before: Zhang Guichun Inventor before: Gu Yongmei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZOU BINGDE ZOU JIHUA WO YANBO ZHANG GUICHUN GU YONGMEI TO: ZOU BINGDE ZOU JIHUA WO YANBO ZHANG GUICHUN |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299 Patentee after: MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Address before: 315104 Ningbo, Yinzhou, Central District, No. Qiming South Road, No. 299 Patentee before: NINGBO MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130904 Assignee: Ningbo Shengyuan Biotechnology Co., Ltd. Assignor: MEDICAL SYSTEM BIOTECHNOLOGY Co.,Ltd. Contract record no.: X2022330000361 Denomination of invention: A creatinine detection reagent Granted publication date: 20150902 License type: Common License Record date: 20220809 |